A message from Nanoform regarding COVID-19
The COVID-19 pandemic is evolving rapidly, and we would like to assure our customers, partners, and suppliers that we are diligently monitoring the situation and follow the most up-to-date World Health Organization, EU, and local government guidelines.
Chemicals Knowledge Hub
Our CBO, Dr. Gonçalo Rebelo de Andrade, discusses with Chemicals…
Nanoform and Orion collaborate on next-generation drug development
Nanoform and Orion Corporation, a Finnish pharmaceutical company, today announced a collaboration to apply Nanoform’s award-winning CESS® technology to new chemical entities.
The Small Molecule Manufacturer
Our CCO, Christian Jones, shared his insights with The Medicine…
Nanoform establishes US subsidiary
Nanoform has established Nanoform USA Inc., a wholly owned subsidiary in the US.
Our CCO, Christian Jones, talks to The Medicine Maker at CPhI Worldwide 2019
Our CCO, Christian Jones, joins The Medicine Maker to discuss…